The aim of this study was to assess the relationship between subtle cardiovascular abnormalities and abnormal sodium handling in cirrhosis. A total of 35 biopsy-proven patients with cirrhosis with or without ascites and 14 age-matched controls underwent two-dimensional echocardiography and radionuclide angiography for assessment of cardiac volumes, structural changes and systolic and diastolic functions under strict metabolic conditions of a sodium intake of 22 mmol/day. Cardiac output, systemic vascular resistance and pressure/volume relationship (an index of cardiac contractility) were calculated. Eight controls and 14 patients with non-ascitic cirrhosis underwent repeat volume measurements and the pressure/volume relationship was reevaluated after consuming a diet containing 200 mmol of sodium/day for 7 days. Ascitic cirrhotic patients had significant reductions in (i) cardiac pre-load (end diastolic volume 106p9 ml; P 0.05 compared with controls), due to relatively thicker left ventricular wall and septum (P 0.05) ; (ii) afterload (systemic vascular resistance 992p84 dyn:s:cm − 5 ; P 0.05 compared with controls) due to systemic arterial vasodilatation ; and (iii) reversal of the pressure/volume relationship, indicating contractility dysfunction. Increased cardiac output (6.12p0.45 litres/ min ; P 0.05 compared with controls) was due to a significantly increased heart rate. Pre-ascitic cirrhotic patients had contractile dysfunction, which was accentuated when challenged with a dietary sodium load, associated with renal sodium retention (urinary sodium excretion 162p12 mmol/day, compared with 197p12 mmol/day in controls ; P 0.05). Cardiac output was maintained, since the pre-load was normal or increased, despite a mild degree of ventricular thickening, indicating some diastolic dysfunction. We conclude that : (i) contractile dysfunction is present in cirrhosis and is aggravated by a sodium load ; (ii) an increased pre-load in the preascitic patients compensates for the cardiac dysfunction ; and (iii) in ascitic patients, a reduced afterload, manifested as systemic arterial vasodilatation, compensates for a reduced pre-load and contractile dysfunction. Cirrhotic cardiomyopathy may well play a pathogenic role in the complications of cirrhosis.
A B S T R A C T
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INTRODUCTION
In cirrhosis, cardiac function, in the absence of intrinsic cardiac disease or clinically evident dilated alcoholic cardiomyopathy, appears to be normal, as indicated by the conventional ejection fraction (EF) [1] . Cardiac output seems to increase appropriately when challenged with an increased pre-load following a transjugular intrahepatic portosystemic stent shunt [2, 3] or after peritoneovenous shunting [4] . However, occasional cases of unexpected death due to heart failure have been reported following liver transplantation [5] , transjugular intrahepatic portosystemic stent shunt [6] and surgical portocaval shunts [7] . This raises the possibility of cardiac dysfunction related to cirrhosis. Indeed, in animal studies, the cardiac pre-load reserve, a parameter of cardiac contractile function, has been documented to be significantly lowered in cirrhotic rats [8] . In another study, cirrhotic rats have also been found to have abnormalities in cardiac β-adrenergic receptors and conduction pathways [9] . These findings suggest that cirrhotic cardiomyopathy does occur. This is supported by reports of mechanical, electrophysiological and structural cardiac changes [10] [11] [12] [13] and decreased cardiac performance, especially in response to stress [10, 11, 14] , in patients with cirrhosis of non-alcoholic aetiologies.
The clinical significance of cirrhotic cardiomyopathy has never been evaluated. Could cirrhotic cardiomyopathy, as a result of ' forward failure ', play a role in the pathogenesis of the abnormal sodium and water homoeostasis and hyperdynamic circulation that accompany cirrhosis ? Thus the aims of the present study were to assess (i) cardiac structural and functional abnormalities in cirrhosis, and (ii) the possible relationship between these abnormalities and abnormal sodium handling in these patients.
MATERIALS AND METHODS
Ethical approval for the study was granted by the Ethics Committee of The Toronto Hospital. All control subjects and patients with cirrhosis gave informed consent for the study.
Patients
A total of 35 patients (32 males and 3 females ; mean age 52p4 years) with biopsy-proven cirrhosis were recruited from the Liver Clinics of The Toronto Hospital. Of these, 16 patients had no history of ascites or diuretic use. Absence of ascites was confirmed by ultrasound before enrolment. These patients were therefore termed preascitic cirrhotic patients. The remaining 19 patients had obvious ascites clinically. Twenty-four patients had alcoholic cirrhosis, but had been abstinent from alcohol for at least 6 months before entering the study. Cirrhosis was related to hepatitis C infection in four patients and to hepatitis B infection in another three. One patient had both alcoholic cirrhosis and hepatitis C infection, while the remaining three patients had cirrhosis due to α " -antitrypsin deficiency, haemochromatosis and steatohepatitis respectively. All patients were stable and had been free of gastrointestinal bleeding within the previous 3 months. Cardiovascular disease was excluded by a normal examination by a cardiologist, a normal ECG and chest X-ray. Intrinsic renal disease was excluded by history, examination of the urinary sediment and confirmation of normal-sized kidneys on ultrasound. Fourteen age-matched healthy individuals with no history of cardiac or renal disease served as controls. Demographics of all study subjects and results of baseline liver function tests, including the Pugh score, in all cirrhotic patients are given in Table 1 .
Study design
Both cardiac structure and function were assessed. Left ventricular systolic and diastolic chamber dimensions, interventricular septal thickness and left ventricular relative wall thickness were measured during twodimensional echocardiograph examination as assessments of cardiac structure [15] . Cardiac systolic or contractile function was assessed non-invasively using radionuclide angiography. The parameters measured were left ventricular volumes, EF and the pressure\volume relationship, a highly reproducible and reliable measure of left ventricular contractility [16, 17] . Diastolic function was assessed using two-dimensional echocardiograph by measuring (i) the E\A ratio (E velocity is early maximal ventricular filling velocity, and A velocity is late diastolic or atrial velocity), an assessment of the atrial contribution of the ventricular volume, (ii) deceleration time, and (iii) isovolumic relaxation time. An increase in the deceleration time of the venous return [13, 18] and an increase in the ventricular relaxation time suggest impedance to ventricular filling, i.e. increased ventricular stiffness or diastolic dysfunction.
The study was performed with all study subjects consuming a metabolic diet containing 22 mmol of sodium and 1.0 litre of fluid per day. Control subjects and pre-ascitic patients do not retain sodium while on this sodium intake, whereas the ascitic patients retain sodium avidly even on this low-sodium diet. This was to permit correlation of cardiac abnormalities with the extent of sodium retention. The control subjects and pre-ascitic cirrhotic patients were then asked to consume a highsodium diet of 200 mmol\day together with a 1.5 litre\day fluid restriction, since pre-ascitic cirrhotic patients have been shown to have subtle sodium retention after remaining on this diet for 7 days [19] . This would permit the relationship between cardiac function and the state of sodium retention to be assessed at an earlier stage of liver cirrhosis. Cardiac dysfunction in cirrhosis 
Protocol
The study began with all study subjects being maintained on a sodium-restricted diet of 22 mmol\day, with a 1 litre fluid restriction per day. Day 1 of the study was the first day of the diet. All diuretics were withheld from the ascitic patients. All study subjects were monitored by daily weighing and 24 h urine collections to determine their urinary sodium excretion. Urinary creatinine concentrations were used as an indicator of completeness of the urine collections. On day 7 of the study, both control subjects and cirrhotic patients, after having fasted and remained supine for at least 6 h, underwent radionuclide angiography for measurement of total central blood volume and cardiac chamber volume in the Nuclear Cardiology Department. The technique for measurement of central blood volume has been described previously [1] . Automatic blood pressure and pulse monitoring (Dinamap, model 845XT ; Critikon, Tampa, FL, U.S.A.) was performed regularly during radionuclide angiography. The peak systolic blood pressure, together with the end systolic volume (ESV), were used to calculate the peak systolic pressure\ ESV relationship, a surrogate index of cardiac contractility [16, 17] . Quality assurance studies in our Nuclear Cardiology Laboratory have established the standard error of the ventricular volume calculation to be less than 5 ml [20] . On the same afternoon, all subjects underwent a two-dimensional echocardiological examination for measurement of cardiac chamber dimensions and parameters of diastolic function.
After completion of the above baseline studies, the control subjects and pre-ascitic cirrhotic patients were placed on a diet containing 200 mmol of sodium and 1.5 litres of fluid per day for a further 7 days. Radionuclide angiography was repeated and the pressure\volume relationship was re-evaluated to assess cardiac contractile function with sodium loading.
Laboratory analysis
Urinary sodium concentrations were determined by flame photometry. Urinary creatinine was measured by the Jaffe reaction.
Calculations
Total central blood volume, pulmonary vascular volumes, left end diastolic volume (EDV) and left ESV were measured directly during radionuclide angiography based on actual cardiopulmonary and blood sample radioactivities. The left-sided systolic stroke volume was calculated as EDVkESV. Cardiac output and systemic vascular resistance were then calculated from standard formulae using stroke volume, heart rate and mean arterial pressure [5] .
Statistical analysis
All results are expressed as meanspS.E.M. Regression analysis was used to determine the relationship between systolic arterial blood pressure and ESV during ingestion of the low-sodium diet. Differences between the three study groups were assessed by analysis of variance, while the differences between the control subjects and the preascitic patients during the period of the high-sodium diet were assessed using the unpaired Student's t test. A P value of 0.05 was considered statistically significant.
RESULTS

Diet of 22 mmol of sodium/day
At the end of 7 days on the low-sodium diet, mean urinary sodium excretion was similar between the control subjects (21p2 mmol\day) and the pre-ascitic cirrhotic patients (19p2 mmol\day), but significantly reduced in the patients with ascites (5p1 mmol\day ; P 0.05 compared with controls and pre-ascitic cirrhotics). Mean urinary creatinine levels during intake of the low-sodium diet in the male subjects were 20.1p0.4 mmol\day for the controls, 18.2p1.2 mmol\day for the pre-ascitic cirrhotic patients and 13.4p1.4 mmol\day for the ascitic 
Assessment of cardiac function
The controls and the pre-ascitic cirrhotics had similar values for systolic blood pressure, mean arterial blood pressure and heart rate. In contrast, the ascitic patients had a significantly lower systolic blood pressure (P 0.05), a normal but slightly lower mean arterial pressure and a significantly higher heart rate (P 0.05) ( Table 2 ). The stroke volume and cardiac chamber volumes were similar between the controls and the pre-ascitic cirrhotic patients, but with the latter tending towards increased chamber volumes. The ascitic cirrhotic patients, however, had lower values of stroke volume, EDV and ESV, with the EDV and ESV being significantly decreased compared with both controls and pre-ascitic patients (P 0.05) ( Table 2 ). The significantly higher heart rate in the ascitic patients resulted in a significantly increased cardiac output when compared with the controls (P 0.05), and the low normal mean arterial pressure resulted in a significantly reduced systemic vascular resistance compared with both the controls and the pre-ascitic cirrhotic patients (P 0.05) ( Table 2) .
(a) Systolic function. The EF was in the normal range in all three study groups, with that in the ascitic patients being significantly higher than in the pre-ascitic patients and the controls (Table 2 ). Keeping in mind that the EF is a ratio between stroke volume and the EDV, the higher EF in the ascitic cirrhotic patients was due to a lower stroke volume divided by a much reduced EDV. This was also associated with significantly smaller left-ventricular dimensions in the ascitic patients, both at the end of diastole and at the end of systole (Table 3) . When the systolic blood pressure was correlated with the leftventricular ESV in the control subjects, a normal physiological relationship of a positive correlation was observed, i.e. the higher the systolic blood pressure, the greater the ESV (Figure 1a) . In contrast, in both the pre-ascitic and ascitic patients, the pressure\volume relationship was reversed, with the larger cardiac volumes being associated with lower systolic blood pressure (Figures 1b and 1c) .
(b) Diastolic function. The isovolumic relaxation time was significantly prolonged in both the pre-ascitic and ascitic patients (Table 3 ). This was associated with a significantly prolonged deceleration time in both patient groups ( Table 3) . The E\A ratio, a measure of the atrial contribution to the EDV, was significantly decreased in the ascitic patients only (P 0.05 compared with controls) ( Table 3 ). The left atrial diameter was significantly increased in both the pre-ascitic and ascitic patients compared with the controls (Table 3) .
Assessment of cardiac structure
The interventricular septal thickness was significantly increased in the pre-ascitic and ascitic patients compared with the controls (Table 3) . The left-ventricular relative wall thickness was also significantly greater in the ascitic patients, but not in the pre-ascitic patients, when compared with the controls (Table 3) .
Diet of 200 mmol of sodium/day
Eight control subjects and 14 pre-ascitic cirrhotic patients consented to sodium loading for 7 days. This subset of pre-ascitic cirrhotic patients had significantly higher EDV and stroke volume values, a trend demonstrated by the group as a whole ( Table 2) . At the end of 7 days on the high-sodium diet, the mean 24 h urinary sodium excretion in the pre-ascitic cirrhotic patients was 162p12 mmol, significantly lower than that in the control subjects (197p12 mmol ; P 0.05), who, unlike the cirrhotics, remained in sodium balance. The control subjects had a weight gain of 2.2p0.4 kg at the end of the sodium loading period, while that in the pre-ascitic patients was 3.8p0.3 kg. There was a significant increase in total central blood volume, EDV and ESV in the control subjects (Table 4 ). In contrast, the pre-ascitic cirrhotic patients only had a significant increase in ESV, and the changes in EDV and central blood volume were not statistically significant.
When the pressure\volume relationship was reexamined in the control subjects, they showed a physio- Table 4 Effects of sodium loading on systemic haemodynamics and cardiac volume measurements in control subjects and patients with pre-ascitic cirrhosis
The low-sodium diet contained 22 mmol of sodium/day, and the high-sodium diet contained 200 mmol of sodium/day. Significance of differences : *P 0.05 compared with controls ; †P 0.05 compared with low-sodium diet.
Controls (n l 8)
Pre-ascitic cirrhosis (n l 14) logical cardiovascular response, i.e. the increase in cardiac volume after sodium loading was associated with an increase in the systolic blood pressure (Figure 2a ). This normal response was observed in all control subjects (Figure 2a) . In contrast, the pre-ascitic cirrhotic patients, as a group, showed a minimal increase in systolic blood pressure, despite a significant increase in ESV (Table 4) .
On analysing the responses of the individual cirrhotic patients to sodium loading, eight patients showed a normal systolic pressure increase associated with the increase in the ESV, whereas the remaining six patients had an abnormal response, with a reduction in their systolic blood pressure in association with an increase in ESV (Figure 2b ). Those pre-ascitic cirrhotic patients who showed an abnormal response to sodium loading had a significantly higher mean peak systolic blood pressure (131p5 mmHg) compared with those who showed a normal response (114p4 mmHg ; P l 0.02).
DISCUSSION
Cirrhotic patients demonstrated both structural and functional cardiac abnormalities, resulting in systolic and diastolic dysfunction, which appeared to correlate with the severity of the liver disease. Cardiac systolic performance is governed by the preload, the afterload and cardiac contractility. The preload, in turn, is best expressed non-invasively as the EDV, which is determined by both the volume of the venous return and the stiffness or the diastolic function of the heart. The pre-load in the pre-ascitic cirrhotic patients was normal or even increased, despite evidence of diastolic abnormalities. In contrast, the patients with ascitic cirrhosis, who also had diastolic dysfunction, demonstrated significantly reduced cardiac pre-load or EDV. Could the difference in pre-load between the preascitic and ascitic cirrhotic patients simply be a function of the severity of the diastolic dysfunction ? Indeed, the ascitic patients had a thicker left ventricular wall and a lower E\A ratio, indicating greater impedance to venous inflow. An increased venous return, indirectly reflected by a significantly increased central blood volume in the pre-ascitic cirrhotic patients, appeared to have been able to maintain the pre-load. In contrast, the same increase in central blood volume in the ascitic cirrhotic patients resulted in a smaller pre-load in the presence of a stiffer left ventricle. In other words, the pre-ascitic cirrhotic patients would have had a reduced pre-load if it were not for their intravascular volume expansion, and the ascitic cirrhotic patients were relatively ' under-volumed ' for their degree of diastolic dysfunction. That is, the stiff heart has prevented adequate filling of the ventricle. This does not mean that the ascitic cirrhotic patients had a reduced total blood volume, but rather that the blood volume was maldistributed elsewhere, such as the splanchnic vascular bed, rather than to the heart.
The afterload is largely determined by the impedance to ventricular ejection, which is represented noninvasively as the systemic vascular resistance. Normally, lower impedance should lead to a greater stroke volume. Decreased afterload was evident in the ascitic, but not the pre-ascitic, patients. The presence of excess vasodilators, especially in decompensated cirrhosis, is thought to be responsible for the systemic arterial vasodilatation [21] , which has been implicated in the hyperdynamic circulation and sodium retention in these patients [22] . Despite the many detrimental effects of systemic arterial vasodilatation in cirrhosis, it seems that Nature has provided the perfect solution to the development of cirrhotic cardiomyopathy. The reduction in afterload has probably helped to protect the cirrhotic heart from florid decompensation, especially in ascitic patients.
Finally, cardiac contractility is best determined by a pressure\volume relationship, simplified as the peak systolic pressure\ESV ratio ; the greater the ratio, the better the intrinsic contractility of the heart [23] . Contractility was abnormal in both the pre-ascitic and ascitic cirrhotic patients, as estimated by the peak systolic pressure\volume relationship. This seems paradoxical in the presence of a ' normal ' EF. One must keep in mind that EF is an extensively load-dependent parameter. It is simply a mathematical expression of the ratio between the stroke volume and the EDV. In cirrhosis, the change in stroke volume parallels the change in the EDV, thereby maintaining the EF in the ' pseudonormal ' range. Despite the presence of contractile dysfunction, the pre-ascitic cirrhotic patients were able to maintain a normal stroke volume and mean arterial pressure because of their normal pre-load and afterload. However, the response of the pre-ascitic cirrhotic patients was abnormal when challenged by a physiological stress, such as a highsodium diet ; an increased ESV due to the sodium load resulted in overall unchanged systolic pressure rather than an increase. It appears that, in a subset of pre-ascitic cirrhotic patients who had a higher baseline systolic pressure, the higher afterload had accentuated the contractile dysfunction in the presence of a physiological stress. That is, they did not show the decrease in afterload to protect the heart in conditions of stress. Whether these pre-ascitic cirrhotic patients will develop further complications of cirrhotic cardiomyopathy will require further studies. As a corollary of this observation, it seems prudent to advise pre-ascitic cirrhotic patients with high systolic blood pressure to consume a low-sodium diet. The ascitic cirrhotic patients, unlike the pre-ascitic patients, were unable to generate an adequate stroke volume, despite a significantly reduced afterload. The contractile dysfunction, coupled with a relative decrease in the pre-load, was most probably responsible for this. This decrease in stroke volume in the ascitic cirrhotic patients was partly compensated by increased chronotropy, or the hyperdynamic circulation. A reduced cardiac pre-load seems paradoxical in the presence of an increased total central blood volume in the ascitic cirrhotic patients. Preferential distribution of the central blood volume to the right side of the circulation [24] and to the dilated pulmonary circulation [1] , coupled with decreased compliance of the left ventricle, would have reduced the venous return to the left ventricle.
In contrast with dilating alcoholic cardiomyopathy [25] [26] [27] [28] , cirrhotic cardiomyopathy characterized by normal or increased EF and normal or decreased ventricular volumes is increasingly being reported, in both nonascitic and ascitic patients [10, 13, 14, 29] . Furthermore, evidence of contractile dysfunction has been demonstrated at rest and after exercise [10, 29] , and in response to tilting [14] . The major histological abnormality of the myocardium in such patients was myocardial hypertrophy [30, 31] . One possible explanation for this would be myocardial adaptation to a chronically elevated blood volume [1, 32] . Alternatively, ventricular hypertrophy or remodelling could be related to the trophic effects of activated neurohormonal systems such as noradrenaline [33] , or angiotensin II with or without the synergistic effects of endothelin-1 [34, 35] . Pre-ascitic cirrhotic patients tend to have normal or suppressed circulating levels of neurohormones [32, 36] . However, these may not reflect the intra-organ concentrations, as seen with the renal renin-angiotensin system in pre-ascitic patients [24] and the disparity between the cardiac coronary sinus and systemic levels of atrial natriuretic peptide in cirrhosis [37] . Myocardial contractile dysfunction, in contrast, may be related to the local effects of liberated cytokines [38, 39] , with the generation of nitric oxide and cGMP as intermediaries [40] [41] [42] [43] . In 1992, Lewis and colleagues [44] first reported a decrease in ESV in relation to a higher mean arterial pressure in pre-ascitic cirrhotic patients. Therefore it is of interest that we have found, in the same subgroup of cirrhotic patients, a reversal of the normal physiological response to sodium loading. Perhaps the cardiac abnormalities may be explained by overactivity of the vasoconstrictor systems in response to increased nitric oxide production in cirrhosis.
Given that cardiomyopathy exists in cirrhosis, is there a relationship between myocardial dysfunction, haemodynamic changes, hormonal status and sodium retention in cirrhosis ? Cirrhosis, with the development of portal hypertension, is associated with haemodynamic changes and altered neurohormonal activities. The activated hormonal systems, in turn, appear to play a pathogenic role in the development of cirrhotic cardiomyopathy. Increased production of nitric oxide, while involved in the pathogenesis of myocardial contractile dysfunction, also produces systemic arterial vasodilatation by virtue of its vasodilator properties. The reduction in afterload thus permits the heart to maintain a normal cardiac output even in the presence of contractile dysfunction and a reduced pre-load, as in the ascitic cirrhotic patients. However, an inadequate cardiac response for the extent of the decrease in the afterload may aggravate the sodium handling abnormality that is already present in cirrhosis ; in turn, sodium retention may aggravate myocardial dysfunction, hastening the development of refractory ascites. Thus a ' vicious cycle ' may be set up. Therefore manipulations of any link in this pathophysiological chain may help to improve haemodynamic status, myocardial function and hence sodium handling in cirrhosis.
In summary, patients with decompensated cirrhosis and ascites had a decreased pre-load, decreased afterload and abnormal left-ventricular contractility. They showed an inability to generate a normal stroke volume, and the cardiac output was maintained by an increased heart rate. Pre-ascitic cirrhotic patients, despite their contractile dysfunction, were able to maintain a normal stroke volume because of their normal or increased pre-load. However, those patients with higher mean systolic pressure were unable to increase cardiac performance when challenged by a sodium load. In conclusion, regardless of aetiology, cirrhosis is associated with significant myocardial dysfunction. The pathophysiological changes leading to the development of cirrhotic cardiomyopathy and its consequences may well be involved in the pathogenesis of the hyperdynamic circulation and sodium\water retention which are so commonly observed in these patients.
